allogen

allogen

allergen.
Mentioned in ?
References in periodicals archive ?
The market for cervical cancer testing is enormous and Allogen Laboratories will aid in the speed and quality of our development plans for our non-invasive, protein-based diagnostic.
BULLETIN BOARD: GRTV) announced an agreement with Allogen Laboratories, a wholly owned subsidiary of the Cleveland Clinic Foundation, wherein Allogen will perform testing and validation studies on Grant's protein based HPV/cervical cancer diagnostic technology and kits.
As a part of the agreement, Allogen will screen pre-cancerous and cervical cancer patient samples over Grant's proprietary test to determine the efficacy of the technology.
Allogen Laboratories and Genetic Vectors will collaborate in a $750,000 SBIR Phase II grant application for the rapid identification
OTCBB Symbol: GVEC) announces it has received a letter of support and interest from Allogen Laboratories, the subsidiary of the Cleveland Clinic Foundation responsible for the molecular typing involved in organ and bone marrow transplantation, stating that the Genetic Vectors' yeast detection methodologies are an improvement over current techniques and could be useful in medical centers such as the Cleveland Clinic.
President and CEO of Genetic Vectors said, "Our inaugural relationship with Allogen is a significant achievement for Genetic Vectors.
OTC Bulletin Board: GLIF) today announced an agreement with Allogen Laboratories, a wholly owned subsidiary of the Cleveland Clinic Foundation, wherein Allogen will perform testing and validation studies on Grant's protein-based HPV/cervical cancer diagnostic technology and kits.
As a part of the agreement, Allogen will screen pre-cancerous and cervical cancer patient samples with Grant's proprietary test to determine the efficacy of the technology.
Daniel Cook, Director of Allogen Laboratories, stated, "We are very excited about this opportunity to participate in the validation process of this potentially very significant diagnostic test.
Ireland - Allogen Biotech: Portable rapid detection of food contaminants using next-gen sensors.
Baltimore, MD, has initiated a human clinical trial for Allogen in cancer patients receiving chemotherapy and hematopoietic stem cell transplantation for the treatment of high-risk hematological malignancies, including acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia and non-Hodgkin's lymphoma.
Dusty conditions, allogens in the air or even aggressive physical activity can bring on an attack.